Hope for Inoperable Kidney Cancer (Vol. 25, No. 6, Full Issue)

2021 ◽  
Vol 25 (06) ◽  

For the month of June 2020, in our Features section, we have an article contribution by Dr Jonathan Teh a Consultant Radiation Oncologist at Asian Alliance Radiation & Oncology (AARO) on how SBRT can provide hope for inoperable kidney cancer. Also in the Features section, we commemorate World Health Day with Viatris. In the Columns section, look at how the microbiome can be a gateway to wellness in an article contribution by Daniel Ramón Vidal, Vice President of R&D Health & Wellness at ADM. Also, explore how artificial intelligence and advanced analytics can help in enhancing clinical trial process. In the Spotlights section, we interviewed Jeong Jae Youn, Country Manager for GE Healthcare Singapore & Emerging ASEAN to dive into mammograms and ultrasound methods used for early detection of signs of breast cancer.

2020 ◽  
Vol 9 (1) ◽  
pp. 39-45
Author(s):  
Masoume Rastegar ◽  
Zohreh Mahmoodi ◽  
Sara Esmaelzadeh Saeieh ◽  
Nasibeh Sharifi ◽  
Kourosh Kabir

Introduction: Breast cancer has a high prevalence, constituting a major cause of mortality in women around the world. Health literacy has a vital role in the self-care of chronic diseases such as cancer and is an essential element in the ability of each person to engage with health promotion. The aim of this study was to determine effect of health literacy counselling on selfcare in women after mastectomy. Methods: This study is a randomized, controlled, clinical trial carried out on 72 women with breast cancer after mastectomy in Fars province. The eligible women entered the study using convenience sampling and were then divided into an intervention and a control group through randomized blocks of four. Health literacy questionnaire and self-care questionnaire were distributed among the participants before, immediately after and three weeks following the intervention. Data analysis was performed in SPSS ver.13. Results: The results showed no significant differences between the two groups in terms of their health literacy and self-care scores before the intervention (P=0.299 and 0.059). A comparison of the mean values showed a greater increase in the mean score of health literacy and score of selfcare immediately and three weeks after the intervention in the intervention group compared to the control group. Also, the mean score of the dimensions of self-care in chemotherapy increased over time in the intervention group. Conclusion: The findings of this study confirm the higher effectiveness of counseling with a health literacy approach on overall self-care in chemotherapy and all its dimensions.


Author(s):  
Mridul Sharma

These days one of the major inevitable ailments for females is bosom malignancy. The appropriate medication and early findings are important stages to take to thwart this ailment. Although, it's not easy to recognize due to its few vulnerabilities and lack of data. Can use artificial intelligence to create devices that can help doctors and healthcare workers to early detection of this cancer. In This research, we investigate three specific machine learning algorithms widely used to detect bosom ailments in the breast region. These algorithms are Support vector machine (SVM), Bayesian Networks (BN) and Random Forest (RF). The output in this research is based on the State-of-the-art technique.


Author(s):  
Maianna Macêdo de Sousa ◽  
Sabrina Barreto Figueredo ◽  
Reinaldo Magalhães Fernandes

O câncer de mama é uma neoplasia rara antes dos 35 anos de idade, acometendo em cerca de 99% as mulheres. Ainda possui etiologia desconhecida, no entanto apresenta alguns fatores de risco importantes, tais como: menarca precoce antes dos 12 anos, menopausa tardia acima de 50 anos, primeira gestação acima de 35 anos, nuliparidade, idade, fatores genéticos, além de fatores relacionados à estilo de vida como consumo de tabaco e histórico de consumo de bebidas alcoólicas. No Brasil, o câncer de mama também é o mais incidente (excluídos os tumores de pele não melanoma) em mulheres de todas as regiões, exceto na região Norte, onde o câncer do colo do útero ocupa a primeira posição. De acordo com a Organização Mundial de Saúde (OMS) como ação de prevenção secundária, ou seja, de detecção precoce do câncer de mama, são mencionadas três estratégias complementares entre si, que são: o auto-exame das mamas, o exame clínico e a mamografia, sendo que tais fatores podem ser influenciados pelo nível de escolaridade das mulheres. É incomum a associação com fatores hereditários, sendo de suma importância a detecção e tratamento precoces adequados de forma a contribuir para um prognóstico favorável. Objetivo: Descrever o perfil clínico-epidemiológico das Neoplasias de Mama em pacientes do sexo feminino atendidas no Hospital Regional de Referência de Araguaína-TO, no período de 2000-2015. Metodologia: Quanto à natureza o estudo pode ser classificado como quantitativo, pois se baseará na geração de dados e na análise crítica dos mesmos. Será de caráter descritivo, retrospectivo e documental realizado no Hospital Regional de Referência de Araguaína através de informações que serão coletadas por meio da análise de fichas do Registro Hospitalar do Câncer disponibilizadas pelo Instituto Nacional do Câncer (INCA).Palavras-chave: Câncer de Mama – perfil clínico-epidemiológico e fatores de risco ABSTRACTBreast cancer is a rare neoplasm before 35 years of age, affecting approximately 99% women. Still has unknown etiology, however presents some important risk factors, such as: early menarche before 12 years, late menopause above 50 years, first pregnancy above 35 years, nulliparity, age, genetic factors, in addition to factors related to lifestyle as the consumption of tobacco and history of consumption of alcoholic beverages. In Brazil, breast cancer is also the most incident (excluding non-melanoma skin tumors) in women of all regions, except in the northern region, where the cervical cancer occupies the first position. According to the World Health Organization (WHO) as secondary prevention action, i.e. for early detection of breast cancer, are mentioned three complementary strategies among themselves, which are: the breast self-exam, the clinical examination and mammography, being that such factors may be influenced by the level of education of women. It is uncommon to association with hereditary factors and highlighted the importance of early detection and treatment appropriate to contribute to a favorable prognosis. Objective: To describe the clinical-epidemiological profile of Breast Neoplasms in female patients answered the Regional Hospital of reference in the municipality of Araguaína- TO, in the period 2000-2015. Methodology: As to the nature of the study can be classified as quantitative, because it is based on data generation and critical analysis of the same. Will be a descriptive, retrospective and documentary checks carried out at the Regional Hospital of reference in the municipality of Araguaína- TO through the information that will be collected by means of the analysis of the connectors of the Cancer Hospital Registry made available by the National Cancer Institute. Keywords: Breast Cancer - clinical- epidemiological profile and risk factors


2012 ◽  
Vol 30 (34_suppl) ◽  
pp. 149-149 ◽  
Author(s):  
Minggui Pan ◽  
Anita T. C. Lee ◽  
Samantha A. Seaward ◽  
Aaron Ilano ◽  
Karen House ◽  
...  

149 Background: Cancer clinical trial enrollment is low at approximately 3% in the U.S., and there is an urgent need for improvement. Informing patients clinical trial information early at their initial appointment after the diagnosis of cancer may improve clinical trial enrollment. To this goal, we have developed a system-based multidisciplinary breast cancer clinic (MDBCC) that evaluates all newly diagnosed breast cancer cases and discuss with all patients eligible clinical trials at their initial appointment. Methods: Our MDBCC team consists of a medical and radiation oncologist, breast surgeon, mammographer, pathologist, geneticist, and breast cancer coordinators, who review all newly diagnosed cases in the tumor board (multidisciplinary breast cancer tumor board) prior to patient’s MDBCC appointment. During the MDBCC visit, each individual patient meets separately with a medical oncologist, a radiation oncologist, and a surgeon to discuss their treatment options. Eligible clinical trials are discussed and presented to patients with informed consent. Clinical trial nurses are dedicated for patients to call and meet for further discussion on the eligible trials after the MDBCC visit. Results: The average annual clinical trial enrollment for breast cancer was 9 cases (approximately 3%) between 2000 and 2006 prior to initiating the MDBCC, improved to 53 (approximately 17%) between 2007 and 2011 after the MDBCC was formed. The enrollment into the NSABP and SWOG trials accounts for the large portion of the accrual. Conclusions: Early engagement of patients with clinical trial information in a system-based MDBCC for all newly diagnosed breast cancer patients dramatically improves clinical trial enrollment.


Sign in / Sign up

Export Citation Format

Share Document